These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 27012765)

  • 1. Molecular mechanisms and biomedical applications of glucosamine as a potential multifunctional therapeutic agent.
    Dalirfardouei R; Karimi G; Jamialahmadi K
    Life Sci; 2016 May; 152():21-9. PubMed ID: 27012765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucosamine: an ingredient with skin and other benefits.
    Bissett DL
    J Cosmet Dermatol; 2006 Dec; 5(4):309-15. PubMed ID: 17716251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of anticancer effects of Glucosamine.
    Zahedipour F; Dalirfardouei R; Karimi G; Jamialahmadi K
    Biomed Pharmacother; 2017 Nov; 95():1051-1058. PubMed ID: 28922722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antireactive properties of "chondroprotective" drugs.
    Setnikar I
    Int J Tissue React; 1992; 14(5):253-61. PubMed ID: 1300311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Focusing on glucosamine sulfate.
    Russell AL
    Can Fam Physician; 2004 Jul; 50():980-1; author reply 981. PubMed ID: 15317228
    [No Abstract]   [Full Text] [Related]  

  • 6. Conservative management of spinal osteoarthritis with glucosamine sulfate and chiropractic treatment.
    Gottlieb MS
    J Manipulative Physiol Ther; 1997; 20(6):400-14. PubMed ID: 9272473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Glucosamine and chondroitin sulfate as a possible treatment for osteoarthritis].
    Bijlsma JW
    Ned Tijdschr Geneeskd; 2002 Sep; 146(39):1819-23. PubMed ID: 12382365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosamine therapy for osteoarthritis.
    Towheed TE; Anastassiades TP
    J Rheumatol; 1999 Nov; 26(11):2294-7. PubMed ID: 10555879
    [No Abstract]   [Full Text] [Related]  

  • 9. Ethnopharmacology, phytochemistry, and biological activities of Cymbopogon citratus (DC.) Stapf extracts.
    Ekpenyong CE; Akpan E; Nyoh A
    Chin J Nat Med; 2015 May; 13(5):321-37. PubMed ID: 25986281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders.
    Villa FA; Gerwick L
    Immunopharmacol Immunotoxicol; 2010 Jun; 32(2):228-37. PubMed ID: 20441539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel glucosamine derivative exerts anti-inflammatory actions via inhibition of nuclear factor-kappaB.
    Shin JA; Hwang JS; Kim SY; Oh SK; Nam G; Han IO
    Neurosci Lett; 2013 Aug; 550():162-7. PubMed ID: 23831355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study.
    Murad H; Tabibian MP
    J Dermatolog Treat; 2001 Mar; 12(1):47-51. PubMed ID: 12171689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolism and pharmacological activities of the natural health-benefiting compound diosmin.
    Zheng Y; Zhang R; Shi W; Li L; Liu H; Chen Z; Wu L
    Food Funct; 2020 Oct; 11(10):8472-8492. PubMed ID: 32966476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy.
    Anderson JW; Nicolosi RJ; Borzelleca JF
    Food Chem Toxicol; 2005 Feb; 43(2):187-201. PubMed ID: 15621331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antinociceptive synergy, additivity, and subadditivity with combinations of oral glucosamine plus nonopioid analgesics in mice.
    Tallarida RJ; Cowan A; Raffa RB
    J Pharmacol Exp Ther; 2003 Nov; 307(2):699-704. PubMed ID: 12966152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of glucosamine sulfate on the use of rescue non-steroidal anti-inflammatory drugs in knee osteoarthritis: Results from the Pharmaco-Epidemiology of GonArthroSis (PEGASus) study.
    Rovati LC; Girolami F; D'Amato M; Giacovelli G
    Semin Arthritis Rheum; 2016 Feb; 45(4 Suppl):S34-41. PubMed ID: 26632505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coumarin hybrids as novel therapeutic agents.
    Sandhu S; Bansal Y; Silakari O; Bansal G
    Bioorg Med Chem; 2014 Aug; 22(15):3806-14. PubMed ID: 24934993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The influence of glucosamine on the antiexudative effect of nonsteroidal anti-inflammatory agents].
    Zupanets IA; Drogovoz SM; Bezdetko NV; Rechkiman IE; Semenov AN
    Farmakol Toksikol; 1991; 54(2):61-3. PubMed ID: 1884801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.
    Clegg DO; Reda DJ; Harris CL; Klein MA; O'Dell JR; Hooper MM; Bradley JD; Bingham CO; Weisman MH; Jackson CG; Lane NE; Cush JJ; Moreland LW; Schumacher HR; Oddis CV; Wolfe F; Molitor JA; Yocum DE; Schnitzer TJ; Furst DE; Sawitzke AD; Shi H; Brandt KD; Moskowitz RW; Williams HJ
    N Engl J Med; 2006 Feb; 354(8):795-808. PubMed ID: 16495392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs and product approvals from 1999.
    Gage TW; Taylor SE
    Tex Dent J; 2000 Sep; 117(9):30-47. PubMed ID: 11857846
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.